Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colchicine for large pericardial effusion

Y Adler1, J Guindo, Y Finkelstein

  • 1Department of Cardiology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel.

Clinical Cardiology
|March 10, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperkalemia management in heart failure and chronic kidney disease: a Spanish cost-effectiveness analysis of patiromer informed by the integrated DIAMOND trial and real-world evidence.

BMC health services research·2026
Same author

Vericiguat in heart failure: From scientific evidence to clinical practice.

Revista clinica espanola·2022
Same author

Particle size and cholesterol content of circulating HDL correlate with cardiovascular death in chronic heart failure.

Scientific reports·2021
Same author

Differences in the Interleukin-1β/Soluble ST2 Interplay Between Acute and Chronic Heart Failure.

Journal of cardiovascular translational research·2020
Same author

Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction.

Journal of molecular and cellular cardiology·2019
Same author

Growth differentiation factor-15 is a predictive biomarker in primary ventricular fibrillation: The RUTI-STEMI-PVF study.

European heart journal. Acute cardiovascular care·2018

Colchicine effectively treated large pericardial effusions in two patients when standard treatments failed. This suggests colchicine is a viable option for refractory idiopathic pericarditis with significant effusion.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Idiopathic pericarditis can lead to large pericardial effusions, a condition often managed with nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids.
  • Recurrent pericarditis cases have shown positive responses to colchicine therapy.

Observation:

  • Two patients with large pericardial effusions complicating idiopathic pericarditis were treated with colchicine after conventional therapies proved insufficient.
  • The first patient, a male, deteriorated despite pericardiocentesis and high-dose aspirin.
  • The second patient, a child, did not respond to aspirin and received prolonged corticosteroid treatment.

Findings:

  • Colchicine administration led to complete regression of pericardial effusions in both patients within weeks.
  • The first patient received colchicine instead of aspirin, while the second had corticosteroids rapidly tapered off.

Related Experiment Videos

  • No adverse effects were reported during colchicine treatment, with follow-up showing no recurrence.

    • Implications:

    • Colchicine demonstrates potential efficacy in managing large pericardial effusions unresponsive to NSAIDs and corticosteroids.
    • This finding expands therapeutic options for complex idiopathic pericarditis cases.
    • Further research into colchicine's role in pericardial effusion treatment is warranted.